MissionIR Articles

Exelixis is a biotechnology company focused on the development of small molecule therapies to treat cancer. The company’s proprietary resources and development efforts are focused exclusively on COMETRIQ, its lead product. The company has additionally…

StemCells is a leading developer of cell-based therapeutics and tools for stem cell-based research and drug discovery. StemCells’ lead therapeutic product candidate, HuCNS-SC cells, is currently being developed as a potential treatment for various central…

Horizon Pharma is a biopharmaceutical company focused on the development and commercialization of innovative medicines to target unmet therapeutic needs in the areas of arthritis, pain and inflammatory diseases. The company’s strategy involves commercializing its…

Ohr Pharmaceutical is a pharmaceutical company focused on the clinical development of new drugs to address underserved therapeutic needs in markets that are large and growing. The company is currently focused on two lead compounds:…

Intercept Pharmaceuticals is a clinical-stage biopharmaceutical company utilizing its expertise in bile acid chemistry to develop and commercialize novel therapeutics for the treatment of orphan and more prevalent liver diseases. OCA (obeticholic acid), the company’s…

Tranzyme Pharma is a biopharmaceutical company engaged in the discovery, development and commercialization of novel, mechanism-based therapeutics to treat upper gastrointestinal motility disorders. Though more than 40 percent of people in the U.S. are affected…

Venaxis is an in vitro diagnostic company pursuing clinical development and commercialization of APPY1, its blood-based appendicitis test. Designed to aid in identifying patients at low risk for acute appendicitis, thus enabling more conservative patient…

Anthera Pharmaceuticals is a biopharmaceutical company engaged in developing and commercializing products for the treatment of serious illnesses, such as cardiovascular and autoimmune diseases. The company’s clinical-stage program includes a Phase 2 study of blisibimod,…

RXi Pharmaceuticals is a biotechnology company engaged in the discovery, development and commercialization of innovative therapies to address major unmet medical needs using RNA-targeted technologies. Building on the groundbreaking work of Nobel Laureate and RXi…

Catalyst Pharmaceutical Partners is a development-stage specialty pharmaceutical company engaged in developing and commercializing prescription drugs that target orphan drug diseases as well as disorders of the central nervous system. The company currently has three…

TG Therapeutics is a clinical-stage biopharmaceutical company engaged in acquiring, developing and commercializing pharmaceutical products that are medically important for the treatment of cancer and other underserved therapeutic needs. The company is currently developing two…

Navidea Biopharmaceuticals is a biopharmaceutical company engaged in developing and commercializing precision diagnostics and radiopharmaceutical agents. The company is actively developing four radiopharmaceutical agent platforms: Lymphoseek, NAV4694, NAV5001 and RIGScan. The company aims to deliver…

Eternity Healthcare is a leading medical technology company in the United States. The company’s state-of-the-art medical devices include diagnostic kits, digital cholesterol readers, injection-free needles and many others. The company’s products are sold throughout the…

Antisense Therapeutics is an Australian pharmaceutical drug discovery and development company focused on creating, developing and commercializing novel antisense therapeutics. The company’s strategy involves creating antisense drugs – in collaboration with technology and research partners…

Novavax is a global clinical-stage biopharmaceutical company engaged in creating vaccines to address a wide range of infectious diseases throughout the world. Using innovative technology and new efficient manufacturing approaches, Novavax produces potent vaccine candidates…

MDxHealth is a leading molecular diagnostics company focused on the development and commercialization of advanced epigenetic tests for cancer assessment and personalized patient treatment. The company applies its patented DNA methylation platform and biomarkers to…

Oculus Innovative Sciences is a commercial healthcare company focused on designing, producing and marketing drugs, devices and nutritional products that are innovative, safe and effective. The company is engaged in pioneering innovative solutions in multiple…

Biodel is a specialty pharmaceutical company that is engaged in the development and commercialization of innovative treatments for diabetes that are potentially safer, more effective and more convenient for diabetic patients. The company develops its…

Idera Pharmaceuticals is focused on applying its proprietary Toll-like receptor (TLR) drug discovery platform to create immunomodulatory drug candidates. The company has a clinical development program in autoimmune diseases as well as a collaboration with…

VirtualScopics is a leader in providing quantitative imaging solutions that accelerate drug and medical device development. The company has developed a robust software platform for analyzing and modeling both structural and functional medical images. In…

Cyclacel Pharmaceuticals is a biopharmaceutical company focused on developing oral therapies that target the various cell cycle control phases to treat cancer and other serious diseases. Sapacitabine, the company’s most advanced oral product candidate, is…

Opexa Therapeutics is a biotechnology company focused on developing patient-specific cellular therapies for treating autoimmune diseases like MS. Tcelna, the company’s leading therapy, is a personalized cellular immunotherapy treatment currently in clinical development to target…

Novelos Therapeutics is a pharmaceutical company engaged in the development of novel drugs to treat and diagnose cancer. The company’s cancer-targeted compounds are selectively taken up and retained in cancer cells – including cancer stem…

NeoStem is focused on developing and building on its core capabilities in cell therapy, to capitalize on the burgeoning cell therapy industry as well as cell therapy’s future role in the fight against chronic disease;…

Cleveland BioLabs is a clinical-stage biotechnology company focused on leveraging deep mechanistic understanding of apoptosis – the cell death process – to develop a strong pipeline of compounds chiefly focused on oncology applications and mitigation…

Zealand Pharma is a Copenhagen, Denmark-based biotechnology company specializing in the discovery, optimization and development of novel peptide drugs. The company has an expansive and mature pipeline of drug candidates that have been identified through…

Biotie Therapies is a specialized drug development company engaged in the development of drugs to address diseases of high unmet medical need and significant market potential, including neurodegenerative and psychiatric disorders and inflammatory and fibrotic…

Cytokinetics is a clinical-stage biopharmaceutical company engaged in discovering and developing novel small molecule therapeutics that modulate muscle function to potentially treat serious diseases and medical conditions. The company has various drug candidates at different…

ProMetic Life Sciences is a worldwide biopharmaceutical company that specializes in designing small molecules that mimic unique and specific interactions between proteins, research, development, manufacturing and marketing of various commercial applications derived from its proprietary…

Atossa Genetics, known as The Breast Health Company, is engaged in the prevention of breast cancer through commercializing patented, FDA-approved diagnostic medical devices and patented, laboratory-developed tests for detecting precursors to breast cancer up to…

Targacept is a clinical-stage biopharmaceutical company engaged in developing a varied pipeline of innovative NNR therapeutics for hard-to-treat nervous system diseases and disorders. The company’s clinical pipeline includes multiple Phase 2 product candidates that all…

  Provectus Pharmaceuticals is a biopharmaceutical company specializing in the development of oncology and dermatology therapies. PV-10, the company’s novel oncology drug, is designed to selectively target and destroy cancer cells without harming the surrounding…

NovaBay Pharmaceuticals is a biotechnology company engaged in using its two distinct categories of product offerings – Aganocides and NeutroPhase Skin and Wound Cleanser – to address the large, unmet therapeutic needs of the worldwide…

Agenus is a biotechnology company engaged in developing treatments for cancers and infectious diseases. The company’s focus is on immunotherapeutic products based on strong platform technologies, with multiple product candidates advancing through the clinic, including…

Tonix Pharmaceuticals Holding is focused on the development of innovative prescription medicines for challenging disorders of the central nervous system. Tonix targets conditions characterized by significant unmet medical need, inadequate existing treatments and high patient…

Palatin Technologies is a biopharmaceutical company engaged in the development of targeted, receptor-specific peptide therapeutics for treating diseases that have significant unmet medical need but where there is also commercial potential. The company’s strategy involves…

Lexicon Pharmaceuticals is a biopharmaceutical company engaged in the discovery of breakthrough treatments for human disease. Currently, the company has four drug programs in mid-stage development for diabetes, irritable bowel syndrome, carcinoid syndrome and rheumatoid…

CEL-SCI is a biotechnology company engaged in research and development directed toward improving treatments for cancer and other diseases through utilization of the immune system – the body’s natural defense system. Multikine, the company’s lead…

Repros Therapeutics is a development-stage biopharmaceutical company focused on developing oral small molecule drugs to address major unmet medical needs for male and female reproductive disorders. The company’s primary product candidate is Androxal, an orally…